Literature DB >> 7946809

Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?

A Sigurdsson1, K Swedberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7946809      PMCID: PMC1025598          DOI: 10.1136/hrt.72.3_suppl.s75

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  56 in total

1.  Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis.

Authors:  C C Lang; A M Choy; A D Struthers
Journal:  Clin Sci (Lond)       Date:  1992-11       Impact factor: 6.124

2.  Consequences of impaired arterial baroreflexes in essential hypertension: effects on pressor responses, plasma noradrenaline and blood pressure variability.

Authors:  J S Floras; M O Hassan; J V Jones; B A Osikowska; P S Sever; P Sleight
Journal:  J Hypertens       Date:  1988-07       Impact factor: 4.844

3.  Sequential neurohumoral measurements in patients with congestive heart failure.

Authors:  G S Francis; T S Rector; J N Cohn
Journal:  Am Heart J       Date:  1988-12       Impact factor: 4.749

4.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

5.  Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure.

Authors:  I S Anand; R Ferrari; G S Kalra; P L Wahi; P A Poole-Wilson; P C Harris
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

6.  Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.

Authors:  A T Hirsch; C E Talsness; A D Smith; H Schunkert; J R Ingelfinger; V J Dzau
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

7.  Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction.

Authors:  J Svanegaard; K Angelo-Nielsen; T Pindborg
Journal:  Br Heart J       Date:  1992-07

8.  Adenosine-sensitive ventricular tachycardia. Clinical characteristics and response to catheter ablation.

Authors:  D J Wilber; J Baerman; B Olshansky; J Kall; D Kopp
Journal:  Circulation       Date:  1993-01       Impact factor: 29.690

9.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

Authors:  K Swedberg; P Held; J Kjekshus; K Rasmussen; L Rydén; H Wedel
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

10.  Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure.

Authors:  S S Gottlieb; M L Kukin; D Ahern; M Packer
Journal:  J Am Coll Cardiol       Date:  1989-06       Impact factor: 24.094

View more
  1 in total

Review 1.  Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.

Authors:  G L Plosker; D McTavish
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.